Limosilactobacillus reuteri
Limosilactobacillus reuteri (species-level entry under the updated nomenclature, no specific strain designation) is a reclassified species formerly known as Lactobacillus reuteri. No strain-specific primary or secondary papers are linked to this entry in the research index. The species-level literature includes well-studied strains such as DSM 17648 and ATCC 55730, each with distinct evidence profiles; properties documented for those strains cannot be attributed to this undesignated entry.
Strains of this species
8 strains of Limosilactobacillus reuteri in the index, with 867 linked papers between them.
Limosilactobacillus reuteri DSM 17938
Limosilactobacillus reuteri DSM 17938 (formerly Lactobacillus reuteri DSM 17938) has been studied in multiple randomized controlled trials and at least one published meta-analysis examining infantile colic, episodes of p…
Limosilactobacillus reuteri ATCC PTA 6475
Limosilactobacillus reuteri ATCC PTA-6475 is a human-origin strain that has been studied for gut barrier function, immune modulation, and as a potential adjunct during Helicobacter pylori eradication therapy.
Limosilactobacillus reuteri RC-14
Limosilactobacillus reuteri RC-14 has been studied primarily in the context of urogenital and oral health, often in combination with its companion strain L.
Limosilactobacillus reuteri DSM 17648
Limosilactobacillus reuteri DSM 17648 has been studied for adjunctive use in the context of Helicobacter pylori eradication, a bacterial infection associated with gastric ulcers and gastritis.
Limosilactobacillus reuteri NCIMB 701359
Limosilactobacillus reuteri NCIMB 701359 (formerly Lactobacillus reuteri NCIMB 701359) has been studied primarily through in vitro laboratory models.
Limosilactobacillus reuteri 20016
Limosilactobacillus reuteri 20016 (formerly classified as Lactobacillus reuteri) is a strain within a species well known for colonizing the human gastrointestinal and urogenital tracts.
Limosilactobacillus reuteri ATCC 55730
Limosilactobacillus reuteri ATCC 55730 (the parent strain from which DSM 17938 was derived) has been evaluated in several randomized controlled trials, predominantly in pediatric populations, examining acute gastroenteri…
Limosilactobacillus reuteri JCM 1112
Limosilactobacillus reuteri JCM 1112 is a reference quality sequenced strain of a species widely distributed across mammalian guts, and its metabolic capabilities, including cobalamin (vitamin B12) and reuterin biosynthe…
Discussion
Be the first to comment.
Sign in to join the discussion.